GLP-1 medications require a prescription and physician evaluation
Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes
These medications: Enhance glucose-dependent insulin secretion Suppress glucagon secretion Slow gastric emptying, leading to increased satiety and reduced caloric intake Enhance bone growth by stimulating bone-building stem cells In practical terms, GLP-1 Medications can help many patients achieve meaningful, sustained weight loss, often when lifestyle modifications alone have not been enough
A., Cadena-Ullauri, S., et al
For purposes of this article, when I make reference to GLP-1 agonists and their risks I am really referring to any of the medications found inside this class which includes: These are the brand names of these medications so you also might know them as: Dulaglutide Exenatide Semaglutide Liraglutide Lixisenatide This isnt a full list but it hits all of the major and most popular brands and names
For optimal results in peptide research, reconstitute lyophilized peptides with appropriate solutions like bacteriostatic water and store according to manufacturer guidelines